May is Asthma and Allergy Awareness Month – the ideal time to get the word out on the different types of asthma, as well as the different triggers and treatments.
For more than 20 years, Loyola Medicine's Gottlieb Memorial Hospital has provided the Chicago area with updated allergy counts every weekday during allergy season. This year's official count will resume on Monday, April 1.
Many who suffer from seasonal allergies might be experiencing more severe symptoms this year due to the early start of spring. Rebecca Schapira, D.O., an assistant professor at the Virginia Tech Carilion School of Medicine and an allergist with Carilion Clinic, provides insight on how to detect early allergy symptoms and prepare for their impact on your overall health.
Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens.
Roundup of recent research involving UT Southwestern faculty members: Antibody treatment lowers risk for food allergies; Weight-loss surgery support offered for teens; Racial disparities found among pregnant patients with multiple sclerosis; Gestational age increased at start of COVID-19 pandemic
Researchers at the Keck School of Medicine, University of Southern California, have discovered that a protein called Piezo1 prevents a type of immune cell in the lung from becoming hyperactivated by allergens.
Ants are commonly eaten in some parts of the world, roasted and eaten whole or ground and used to add flavor and texture to dishes. Each species has its own unique flavor, and researchers now report the aroma profiles of four species of edible ants. They will present their results at ACS Spring 2024.
New research from the University of British Columbia reveals a safe path to overcoming food allergies for older children and others who can’t risk consuming allergens orally to build up their resistance.
The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.
The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline: Immunotherapy for Inhalant Allergy today in Otolaryngology–Head and Neck Surgery.
Stage one results from the OUtMATCH clinical trial, published in the New England Journal of Medicine, show that a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as age one could consume without an allergic reaction. Edwin Kim, MD, Corinne Keet, MD, PhD, and Mike Kulis, PhD, are contributing authors.
Allergy sufferers may notice an increase in symptoms due to warmer weather this year, said Rachna Shah, MD, who leads the Loyola Medicine Allergy Count.
Children’s Healthcare of Atlanta and Emory University participated in a nationwide clinical trial showing that a 16-week course of omalizumab, an injectable drug, increased the amount of peanut, tree nuts, egg, milk and wheat that some multi-food allergic children as young as one year could consume without an allergic reaction after exposure.
A study led by Johns Hopkins Children’s Center shows omalizumab — an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions — substantially reduced potentially life-threatening reactions in patients with an allergy to peanut and other common food allergies.